$1.41
-0.09 (-6.00%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,724.8% upside
Low Target
$18.91
Average Target
$25.73
High Target
$33.51
Current Price
$1.41
Current
$1.41
$1.41
Target
$25.73
$25.73
$18.91
$25.73 avg
$33.51
Scenario Analysis
Bear Case
$18.91
1,241.1%
Low target
Base Case
$25.73
+1,724.8%
Avg target
Bull Case
$33.51
+2,276.6%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$29.98
-95.3% from high
52-Week Low
$1.68
+-15.8% from low
Target vs 52W High
$25.73
-14.2% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.5% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -92.0% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |